These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6391305)

  • 1. Monoamine oxidase inhibitor overdose.
    Linden CH; Rumack BH; Strehlke C
    Ann Emerg Med; 1984 Dec; 13(12):1137-44. PubMed ID: 6391305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myocarditis after massive phenelzine overdose.
    Waring WS; Wallace WA
    Eur J Clin Pharmacol; 2007 Nov; 63(11):1007-9. PubMed ID: 17823790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Ping-pong" gaze in severe monoamine oxidase inhibitor toxicity.
    Erich JL; Shih RD; O'Connor RE
    J Emerg Med; 1995; 13(5):653-5. PubMed ID: 8530785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of MAO inhibitor/MDMA interaction: agony after ecstasy.
    Smilkstein MJ; Smolinske SC; Rumack BH
    J Toxicol Clin Toxicol; 1987; 25(1-2):149-59. PubMed ID: 2884326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dangerous monoamine oxidase inhibitor interactions are still occurring in the 1990s.
    Dawson JK; Earnshaw SM; Graham CS
    J Accid Emerg Med; 1995 Mar; 12(1):49-51. PubMed ID: 7640830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of the effects of oxidative stress by the MAO-inhibiting antidepressant and carbonyl scavenger phenelzine.
    Baker G; Matveychuk D; MacKenzie EM; Holt A; Wang Y; Kar S
    Chem Biol Interact; 2019 May; 304():139-147. PubMed ID: 30857888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and specificity of phenelzine and benserazide as inhibitors of benzylamine oxidase and monoamine oxidase.
    Andree TH; Clarke DE
    Biochem Pharmacol; 1982 Mar; 31(5):825-30. PubMed ID: 7082351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
    Alemany R; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stress reduces in vivo inhibition of monoamine oxidase by phenelzine in rat brain.
    Clow A; Glover V; Oxenkrug GF; Sandler M
    Neurosci Lett; 1989 Dec; 107(1-3):331-4. PubMed ID: 2616044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of aromatic L-amino acid decarboxylase and tyrosine aminotransferase by the monoamine oxidase inhibitor phenelzine.
    Dyck LE; Dewar KM
    J Neurochem; 1986 Jun; 46(6):1899-903. PubMed ID: 2871132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevation of rat brain tyrosine levels by phenelzine is mediated by its active metabolite β-phenylethylidenehydrazine.
    Matveychuk D; Nunes E; Ullah N; Aldawsari FS; Velázquez-Martínez CA; Baker GB
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():67-73. PubMed ID: 24607770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].
    Nolen WA
    Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1940-3. PubMed ID: 14574774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic treatment with the monoamine oxidase inhibitor phenelzine increases hypothalamic-pituitary-adrenocortical activity in male C57BL/6 mice: relevance to atypical depression.
    Kier A; Han J; Jacobson L
    Endocrinology; 2005 Mar; 146(3):1338-47. PubMed ID: 15564336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The monoamine oxidase inhibitor phenelzine enhances the discriminative stimulus effect of nicotine in rats.
    Wooters TE; Bardo MT
    Behav Pharmacol; 2007 Nov; 18(7):601-8. PubMed ID: 17912044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine oxidase-inhibiting properties of SR 95191, a new pyridazine derivative, in the rat: evidence for selective and reversible inhibition of monoamine oxidase type A in vivo but not in vitro.
    Kan JP; Steinberg R; Leclercq J; Worms P; Biziere K
    J Neurochem; 1988 Apr; 50(4):1137-44. PubMed ID: 3346672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacology tyramine challenge study to determine the selectivity of the monoamine oxidase type B (MAO-B) inhibitor rasagiline.
    Goren T; Adar L; Sasson N; Weiss YM
    J Clin Pharmacol; 2010 Dec; 50(12):1420-8. PubMed ID: 20445015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoamine oxidase inhibitors phenelzine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in patients with major depression: relationship to clinical improvement.
    Celada P; Pérez J; Alvarez E; Artigas F
    J Clin Psychopharmacol; 1992 Oct; 12(5):309-15. PubMed ID: 1282522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The opposite effect of isotype-selective monoamine oxidase inhibitors on adipogenesis in human bone marrow mesenchymal stem cells.
    Byun Y; Park J; Hong SH; Han MH; Park S; Jung HI; Noh M
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3273-6. PubMed ID: 23611731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine oxidase inhibition by phenelzine and brofaromine in healthy volunteers.
    Bieck PR; Firkusny L; Schick C; Antonin KH; Nilsson E; Schulz R; Schwenk M; Wollmann H
    Clin Pharmacol Ther; 1989 Mar; 45(3):260-9. PubMed ID: 2920501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperthermia, rhabdomyolysis, and myoglobinuric renal failure after recreational use of cocaine.
    Menashe PI; Gottlieb JE
    South Med J; 1988 Mar; 81(3):379-81. PubMed ID: 3347864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.